These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 44462)

  • 21. [Treatment of dyskinesias with tiapride (author's transl)].
    Kocher R; Hobi V
    Sem Hop; 1980 Dec 18-25; 56(47-68):2033-4. PubMed ID: 6109379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Additional possibilities for correction of movement disorders induced by neuroleptics in patients with schizophrenia].
    Semenikhin DG; Kuchaeva AV; Karpov AM; Mikhaĭlova EB; Murav'eva AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):78-80. PubMed ID: 24429952
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of tiapride in tardive dyskinesia.
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J
    Psychopharmacology (Berl); 1985; 85(2):236-9. PubMed ID: 3925489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
    Greil W; Auberger S; Haag H; Rüther E
    Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists].
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J; Chateau R
    Rev Neurol (Paris); 1982; 138(5):409-13. PubMed ID: 7146725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of tardive dyskinesia.
    Roos RA; Buruma OJ; de Wolff FA
    Clin Neuropharmacol; 1988 Aug; 11(4):386. PubMed ID: 3061638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Present-day treatment of dyskinesias (author's transl)].
    Fonsegrive J
    Sem Hop; 1979 Jan 8-15; 55(1-2):88-9. PubMed ID: 34220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
    Wilbur R; Kulik FA
    Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820
    [No Abstract]   [Full Text] [Related]  

  • 30. [Concerning the treatment of a late dyskinesia by Tiapridal (author's transl)].
    Ducamin JP; Lutrand JC
    Sem Hop; 1978 Sep 8-15; 54(21-24):762-3. PubMed ID: 31001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dosage of neuroleptics (author's transl)].
    Haase HJ
    MMW Munch Med Wochenschr; 1980 Dec; 122(50):1808-13. PubMed ID: 6110184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiapride in levodopa-induced involuntary movements.
    Mejer Nielsen B
    Acta Neurol Scand; 1983 Jun; 67(6):372-5. PubMed ID: 6351529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benzamide tiapride: treatment of extrapyramidal motor and other clinical syndromes.
    Dose M; Lange HW
    Pharmacopsychiatry; 2000 Jan; 33(1):19-27. PubMed ID: 10721880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A; dachary JM; Marie C; Oules J; Pagot R; Sales M; Vauterin C
    Encephale; 1976; 2(2):115-21. PubMed ID: 776591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
    Chaudhry R; Radonjic D; Waters B
    Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382
    [No Abstract]   [Full Text] [Related]  

  • 39. A pharmacological and theoretical comparison of high and low potency neuroleptics.
    Zavodnick S
    J Clin Psychiatry; 1978 Apr; 39(4):332-6. PubMed ID: 24619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trial of tiapride in patients with dyskinesia (author's transl)].
    Chouza C; Romero S; Lorenzo J; Camano JL; Fontana AP; Alterwain P; Cibils D; Gaudiano J; Feres S; Solana J
    Sem Hop; 1982 Mar; 58(12):725-33. PubMed ID: 6283645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.